drugset
drugset / Trial / NCT04163523

Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects

NCT04163523 ↗

Phase 1 Completed 18 enrolled BeiGene
RandomizedSequentialOpen-labelBasic science

Summary

Phase 1 study in healthy subjects to determine the effect of food on the pharmacokinetics of BGB-3111.

Timeline

Start
2016-05-25
Primary completion
2016-07-21
Completion
2016-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Zanubrutinib Small molecule 320 mg Oral

Indications

No indication recorded.